Cargando…
Novel strategy of sirolimus plus thymalfasin and huaier granule on tumor recurrence of hepatocellular carcinoma beyond the UCSF criteria following liver transplantation: A single center experience
Although liver transplantation (LT) lengthens the survival time of patients with hepatocellular carcinoma (HCC), LT patients exhibit a high recurrence rate; particularly those that had advanced HCC associated with the tumor biological characteristics and long-term application of immunosuppressants....
Autores principales: | Zhou, Lin, Pan, Li-Chao, Zheng, Yong-Gen, Du, Guo-Sheng, Fu, Xiao-Qian, Zhu, Zhi-Dong, Song, Ji-Yong, Liu, Zhi-Jia, Su, Xiang-Zheng, Chen, Wen, Zheng, De-Hua, Suo, Long-Long, Yang, Shao-Zhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126158/ https://www.ncbi.nlm.nih.gov/pubmed/30214575 http://dx.doi.org/10.3892/ol.2018.9226 |
Ejemplares similares
-
Reduction of FoxP3(+) Tregs by an immunosuppressive protocol of rapamycin plus Thymalfasin and Huaier extract predicts positive survival benefits in a rat model of hepatocellular carcinoma
por: Zhou, Lin, et al.
Publicado: (2020) -
Effects of adjuvant huaier granule therapy on survival rate of patients with hepatocellular carcinoma
por: Shi, Ke, et al.
Publicado: (2023) -
Salvage Liver Transplantation for Recurrent Hepatocellular Carcinoma within UCSF Criteria after Liver Resection
por: Liu, Fei, et al.
Publicado: (2012) -
Thymalfasin, a promising adjuvant therapy in small hepatocellular carcinoma after liver resection
por: He, Chao, et al.
Publicado: (2017) -
Transarterial chemoembolization combined with Huaier granule for the treatment of primary hepatic carcinoma: Safety and efficacy
por: Zhao, Guang Sheng, et al.
Publicado: (2017)